Dear member,

Our work would not be possible without financial support. We would like to thank the Ministry of Health and Social Security for its annual contribution, but this alone is not enough to finance all our activities. We are therefore also dependent on donations and membership fees. After 30 years, it will unfortunately be necessary in 2025 to adjust our contribution to the increased costs in order to continue our work be able to continue our work without restrictions. We hope for your understanding and your continued support in the interests of all patients.

For 2025, we are proposing a single membership fee of €50 per household.

We appreciate the trust you have placed in us and send you our best regards.

Your PVL team

The Patiente Vertriedung would like to wish to all of you a very merry festive season and a Happy New Year when it arrives.

Please note that our office will be closed during the holidays, from December 23rd 2024, until January 3rd, 2025 inclusive.

The association Lipödem Lëtzebuerg Asbl decided at its recent Extraordinary General Meeting to change its name to Lipödem Lymphödem Lëtzebuerg Asbl (3L). Since its creation Lipödem Lëtzebuerg Asbl has been a member of AGORA.

Here is their official press release:

The CNS has just published a major overhaul of their website www.cns.lu.

The site is at this date only available in French.

A new service available from 1 December 2024 on is the electronic submission of a certificate of incapacity for work. This can be done using a new online form @ cns.public.lu/fr/formulaire-declaration-incapacite-travail

The medical center AU VAL FLEURI has moved!

You can find the medical center of Luxembourg City since November 4, 2024 at its new address @ 5 rue des Primeurs; L-2361 Strassen

How to consult at a medical center?

Consultations are now done without an appointment for the 3 medical centers.

The telephone switchboard is accessible during the opening hours of the medical centers at (+352) 20 333 111.

The medical centers are accessible

• During the week: from 8 p.m. to midnight
• Saturday, Sunday and on public holidays: from 8 a.m. to midnight

À la suite de la notification de la Direction de la santé, le ministère de la Santé et de la Sécurité sociale informe qu’une notification de sécurité concernant certains modèles de pompes à insuline de la marque Medtronic MiniMed a été émise par Medtronic USA, représenté en Europe par Medtronic B.V. (Pays-Bas). Cette mesure vise à prévenir d’éventuels risques de santé liés à l'utilisation de ces dispositifs.

Problème identifié

Medtronic a constaté une réduction prématurée de la durée de vie de la batterie sur certains modèles de pompes à insuline MiniMed. Ce dysfonctionnement peut entraîner un arrêt imprévu de l'administration d'insuline, particulièrement si la pompe a subi des impacts, des chocs ou des chutes, susceptibles d'endommager ses composants internes.